CMV Sampling Device for Pseudomonas Volatile Biomarker Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting Pseudomonas aeruginosa, particularly in breath analysis, face challenges due to low concentrations and small sample volumes, making it difficult to consistently and sensitively identify the bacterium using headspace sampling.
Innovation Solution
A method involving capillary microextraction of volatiles (CMV) sampling devices coated with sol-gel derived PDMS, coupled with gas chromatography-mass spectrometry (GC/MS), to absorb and analyze biomarkers like 2-aminoacetophenone and undecene from the gaseous headspace, allowing for the detection of Pseudomonas aeruginosa without the need for reference standards.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If headspace sampling is used to detect volatile biomarkers from Pseudomonas aeruginosa, then the non-invasive breath analysis capability is achieved, but the low concentration of components and small sample volume make consistent and sensitive detection difficult
Solution Approach 1:
The patent applies local quality by using a specifically engineered sorbent material with tailored properties (porosity, surface area, chemical composition) placed at the local site of volatile capture in the breath sampling device. This localized optimization of material properties enhances the capture efficiency of volatile biomarkers from the limited breath sample, resolving the contradiction between non-invasive sampling and detection sensitivity.
Solution Approach 2:
The patent utilizes porous sorbent materials with optimized pore structures to increase the surface area available for volatile biomarker adsorption. The porous structure allows efficient trapping of volatile compounds from the small breath sample volume while maintaining the non-invasive nature of the sampling process, thereby improving measurement precision without sacrificing ease of operation.
2Adaptability or versatility
If headspace sampling is used to analyze volatile components, then selective sampling of volatile species is achieved, but the low concentration of components in headspace makes trace compound detection problematic
Solution Approach 1:
The patent applies the extraction principle by using a specialized sorbent material that selectively captures volatile biomarkers from the breath headspace. The sorbent extracts the trace volatile compounds (such as 2-aminoacetophenone and other Pseudomonas-specific volatiles) from the large volume of headspace gas, concentrating them into a small volume suitable for detection by GC-MS, thus resolving the contradiction between selective sampling and sufficient analyte quantity.
Solution Approach 2:
The patent employs composite sorbent materials combining multiple functional components (e.g., adsorbents, absorbents, or chemically modified materials) to enhance both the selectivity and capacity for volatile biomarker capture. The composite structure allows simultaneous achievement of selective sampling capability and high concentration of trace volatiles, overcoming the limitation of low component concentration in headspace.
3Reliability
If conventional detection methods are used for Pseudomonas aeruginosa, then standard diagnostic procedures are maintained, but the ability to consistently detect the bacterium in breath samples with high sensitivity is insufficient
Solution Approach 1:
The patent replaces conventional mechanical/cultural detection methods with a chemical analysis approach using gas chromatography-mass spectrometry (GC-MS). This substitution enables highly sensitive detection of volatile biomarkers produced by Pseudomonas aeruginosa in breath samples, achieving measurement precision and sensitivity that conventional methods cannot provide, while maintaining diagnostic reliability through specific biomarker identification.
Solution Approach 2:
The patent changes the detection parameter from direct bacterial detection (culture-based) to detection of volatile chemical biomarkers (GC-MS-based). This parameter change allows for much higher sensitivity in detecting Pseudomonas aeruginosa presence, as the volatile biomarkers can be detected at trace concentrations that are not achievable with conventional cultural or microscopic methods, thereby improving measurement precision while maintaining diagnostic reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables sensitive and consistent detection of Pseudomonas aeruginosa, differentiating it from other bacteria based on volatile biomarkers, even in complex matrices, with high throughput and quantitative analysis capabilities.
Implementation Method 1
contacting at least a portion of the gaseous headspace with a capillary microextraction of volatiles (CMV) sampling device to absorb at least one component of the headspace by the CMV sampling device
Implementation Method 2
The analytical device can be a gas chromatograph coupled to a mass spectrometer (GC/MS)
Implementation Method 3
a gas chromatograph coupled to a mass spectrometer (GC/MS)
Data Source
AI summary
A method of determining the presence of Pseudomonas involves establishing a gaseous headspace over a surface suspected of containing at least one Pseudomonas strain and contacting at least a portion of the gaseous headspace with a capillary microextraction of volatiles (CMV) sampling device to absorb at least one component of the headspace by the CMV sampling device. The component loaded CMV sampling device is coupled to an injection port of an analytical device where the components are desorbed into the analytical device, where components are separated, detected, and identified to determine if one or more of the identified components is a biomarker for at least one Pseudomonas strain.